BackTcr2 Therapeutics Overview

Tcr2 Therapeutics Total Liabilities

Tcr2 Therapeutics's total liabilities is $50M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$50.18M
26.13% YoYΔ $-17.75M vs prior year quarter

Peer trimmed avg / median

Loading

Tcr2 Therapeutics Total Liabilities History

Loading

Tcr2 Therapeutics vs. peers: Total Liabilities Comparison

Loading

Tcr2 Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tcr2 Therapeutics (TCRR) FAQ

As of the most recent data (March 2023), TCRR shows a total liabilities of $50M. That compares with $68M in the prior-year period — down 26.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TCRR's total liabilities is now $50M (was $68M) — a 26.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Tcr2 Therapeutics is outperforming or lagging.

Tracking TCRR's total liabilities over time shows whether Tcr2 Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $68M in the prior-year period — down 26.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Tcr2 Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $50M) with ownership activity and broader fundamentals.

Tcr2 Therapeutics's total liabilities is $50M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.